System Transmission

Top Signal

100#1 JOB

Activity

2180Ripe

+936 today

System

Live1m

Terminal Asset View

stockNASDAQ

OABI

$1.79-3.24%

OmniAb Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

30Overripe

Live Analysis Active

Company Mission

OmniAb creates technology that helps pharmaceutical companies discover antibodies, which are proteins that can fight diseases. Drug developers use this platform to find potential treatments faster and more efficiently. The company makes money by licensing its technology to these partners and earning fees from their use.

OAB

Industry Context

OmniAb operates in the biotechnology sector, specifically in antibody discovery. This industry helps pharmaceutical companies develop new medicines by finding specific antibodies that can target diseases. When biotech funding is strong, companies like OmniAb benefit from more partnerships, but when funding tightens, growth can slow down.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

61Matrix

Market Momentum

47.0— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-3.24%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing OABI across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:37 AM UTC

As-of 03-15-2026 07:22 UTC

Develops antibody discovery technology for drug companies and earns money by licensing its platform and collecting royalties on resulting medicines.

Price below key moving averages for several weeks, suggesting a downtrend as sellers maintain control showing consolidation pattern.

Biotech sector faces funding challenges as interest rates remain high, creating headwinds for discovery platform companies, suggesting platform.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...